Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
38,512,859
-
Total 13F shares
-
33,601,118
-
Share change
-
-2,105,737
-
Total reported value
-
$164,645,000
-
Price per share
-
$4.90
-
Number of holders
-
58
-
Value change
-
-$37,248,679
-
Number of buys
-
31
-
Number of sells
-
32
Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q4 2021
As of 31 Dec 2021,
Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,601,118 shares.
The largest 10 holders included
Novo Holdings A/S, Vivo Capital, LLC, CITADEL ADVISORS LLC, Sofinnova Investments, Inc., RA CAPITAL MANAGEMENT, L.P., SUVRETTA CAPITAL MANAGEMENT, LLC, Pivotal bioVenture Partners Investment Advisor LLC, BlackRock Inc., FMR LLC, and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
58
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.